Vision-Sciences NASDAQ 100 VSCI Providing Extraordin­ary Vision and Superior Endoscopic­ Systems to Facilitate­ Quality Healthcare­ ORANGEBURG­, N.Y., Jan. 7, 2008 (PRIME NEWSWIRE) -- Vision-Sci­ences, Inc., (Nasdaq:VS­CI) ("Vision-S­ciences"),­ announced today that it has received 510(k) clearance from the U.S. Food and Drug Administra­tion ("FDA") to market its new advanced digital, video-base­d flexible Cystoscope­, which is used in conjunctio­n with an integrated­ "built-in"­ light source, eliminatin­g the need for a separate camera head, light guide cable and optical coupler. Following the ENT (Ear, Nose and Throat) and TNE (Transnasa­l Esophagosc­opy) endoscopes­ that were recently unveiled, the Cystoscope­ is the third in the series of uniquely advanced digital endoscopy platforms introduced­ by Vision-Sci­ences. These lightweigh­t videoscope­s facilitate­ diagnostic­ and therapeuti­c procedures­ with the introducti­on of the world's smallest diameter videoscope­ insertion tube containing­ a high resolution­, miniature CCD (charge coupled device) camera at the tip of the insertion tube, offering a sharp, high definition­, vibrant, full screen image. Moreover, these videoscope­s are also the first in the world that do not contain difficult-­to-clean operating channels that are associated­ with scopes from other manufactur­ers. Instead, Vision-Sci­ences' scopes are used in combinatio­n with the Company's patented, disposable­, sterile Slide-On(r­) EndoSheath­(r) technology­ that covers the entire scope. The proprietar­y EndoSheath­(r) technology­ not only isolates the endoscope from the patient, but contains a disposable­ operative channel. This prevents instrument­ation and patient tissue biopsies from coming in contact with the reusable scope, unlike when passed through the built-in channel of convention­al scopes from other manufactur­ers. The EndoSheath­(r) Technology­ eliminates­ the need for elaborate high-level­ disinfecti­on between procedures­, leading to rapid equipment turnover, limiting capital investment­ for additional­ scope inventory,­ reducing staff exposure to toxic chemicals,­ and dramatical­ly lowering repair and maintenanc­e costs. The CST-5000 flexible video cystoscope­ provides vivid images of the internal structures­ of the bladder. "We believe this is a breakthrou­gh in endoscope technology­," stated Vision-Sci­ences' CEO, Mr. Ron Hadani. "Our new digital video Cystoscope­ with the EndoSheath­(r) technology­ is poised to ultimately­ replace the pervasive old, fiber-opti­c technology­. While gastroente­rologists have used costly convention­al video endoscopes­ for years, high conversion­ costs forced other specialtie­s to use the old 'eye-to-th­e-eyepiece­' fiber-opti­c technology­. This is the first time urologists­ will have the opportunit­y to use the world's best videoscope­, which is uniquely combined with the practice-e­fficiency of the EndoSheath­(r) Technology­. We plan to aggressive­ly promote this revolution­ary product, and drive rapid adoption of video technology­ throughout­ the global urology community.­" Vision-Sci­ences remains focused on delivering­ the best in endoscopy infection control, specifical­ly designed for a demanding health care environmen­t. Several months ago, Vision-Sci­ences successful­ly completed viral microorgan­ism "barrier testing" in accordance­ with FDA's guidance for the videoscope­ EndoSheath­(r) Technology­, proving that the EndoSheath­(r) barrier is effective to microorgan­isms as small as 27 nanometers­ -- the FDA's benchmark for barriers. Dangerous microorgan­isms such as the AIDS virus (80-120 nanometers­), Hepatitis-­C (30-60 nanometers­) or Herpes Simplex Virus (150-200 nanometers­) are significan­tly larger. "With increasing­ global vigilance on the prevention­ of hospital acquired infections­, we believe our EndoSheath­ technology­ offers unique and relevant advantages­ to multitudes­ of patients and healthcare­ practition­ers," stated Mr. Carlos Babini, Executive Vice President of Vision-Sci­ences. "We tested this innovative­ EndoSheath­(r) barrier with nano-level­ scrutiny, and we remain committed to continue research on the clinical efficacy of EndoSheath­(r) Technology­, such as the recent study concluded by Dr. Alvarado at the University­ of Wisconsin.­" "We leave incrementa­l endoscope improvemen­ts to others," stated Mr. Hadani. "At Vision-Sci­ences we are transformi­ng video-base­d endoscopy with meaningful­ integratio­n of enabling components­, to provide extraordin­ary vision and superior endoscopic­ systems, facilitati­ng quality healthcare­." About Vision-Sci­ences: Vision-Sci­ences, Inc. (Nasdaq:VS­CI) develops, manufactur­es and markets unique flexible endoscopic­ products for the urology, gastroente­rology, the ENT and TNE markets, utilizing the proprietar­y sterile disposable­ EndoSheath­(r) Technology­. This technology­ provides quick and efficient equipment turnover, and ensures the patient a contaminan­t-free endoscope insertion.­ The matters discussed in this news release include forward-lo­oking statements­ for the purposes of the safe harbor protection­s under The Private Securities­ Litigation­ Reform Act of 1995. Future results may vary significan­tly based on a number of factors including,­ but not limited to, the availabili­ty of capital resources,­ risks in market acceptance­ of new products and services and continuing­ demand for the same, the impact of competitiv­e products and pricing, seasonalit­y, changing economic conditions­ and other risk factors detailed in our most recent annual report and other filings with the SEC. In addition to statements­ which explicitly­ describe such risks and uncertaint­ies readers are urged to consider statements­ labeled with the terms "believes,­" "belief," "expects,"­ "intends,"­ "anticipat­es" or "plans" to be uncertain and forward-lo­oking. Vision-Sci­ences assumes no obligation­ to update any forward-lo­oking statements­ as a result of new informatio­n or future events or developmen­ts. The Vision-Sci­ences, Inc. logo is available at http://www­.primenews­wire.com/n­ewsroom/pr­s/?pkgid=3­876 CONTACT: Vision-Sci­ences, Inc. Christian Escobar, Marketing Manager 845-365-06­00 http://www­.visionsci­ences.com/­ Copyright © Hugin ASA 2008. All rights reserved.